Dukic \'-Ott A, Thommes M, Remon J P, et al. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review[J]. Eur J Pharm Biopharm, 2009, 71(1): 38.
Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs[J]. Drug Discov Today, 2007, 12(23/24): 1068.
[35]
Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions[J]. Eur J Pharm Biopharm, 2000, 50 (1): 47.
[36]
Rao V M, Zannou E A, Stella V J. Design of tablets for the delayed and complete release of poorly water-soluble weak base drugs using SBE7M-β-CD as a solubilizing agent[J]. J Pharm Sci, 2011, 4(100): 1576.
[37]
Kohli K, Chopra S, Dhar D, et al. Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability[J]. Drug Discov Today, 2010, 15(21/22): 958.
[38]
Charman S A, Charman W N, Rogge M C, et al. Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound[J]. Pharm Res, 1992, 9(1): 87.
Yu Gao, Wangwen Gu, Lingli Chen, et al. The role of daidzein-loadedsterically stabilized stabilized solid lipid nanoparticles in therapy for cardio-cerebrovascular diseases[J]. Biomaterials, 2010, 29(30): 4129.
[42]
K Dwiecki, G Neunert, P Polewski, et al. Antioxidant activity of daidzein, a natural antioxidant, and its spectroscopic properties in organic solvents and phosphatidylcholine liposomes[J]. J Photochem Photobiol B, 2009, 96(3): 242.
[43]
Müller R H, M？der K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery——a review of the state of the art[J]. Eur J Pharm Biopharm, 2000, 50 (1): 161.
[44]
Hu L, Tang X, Cui F. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs[J]. J Pharm Pharmacol, 2004, 56(12): 1527.
